Skip to main content
. 2021 Nov 22;12:780937. doi: 10.3389/fphar.2021.780937

FIGURE 6.

FIGURE 6

Comparison of the simulated mean Cmax (A) and CL (B) of apatinib in HVs, in HIs with Child–Pugh A, B, or C, as well as in moderate and severe RIs.